@FiercePharma: Bristol will have a tough time replacing 'string of pearls' strategist Levin, Bloomberg says. Story | Follow @FiercePharma
> Sanofi ($SNY) repurchased €1.074 billion worth of its own shares in 2011, or about 1.61% of its capital, at an average price of €49.6 euros per share. News
> Actos-related liability lawsuits against Takeda Pharmaceutical will be consolidated in one federal court in Louisiana, a multidistrict litigation panel determined. Item
> Pfizer's ($PFE) Prevnar 13 won FDA approval for people 50 years of age and older to prevent pneumonia and other diseases caused by Streptococcus pneumoniae. Release
> Lundbeck said its new epilepsy drug Onfi is now available in the U.S. Story
> India's Lupin won FDA approval for fenofibrate tablets for use as a dietary supplement; they're a generic version of Abbott Laboratories' ($ABT) prescription drug Tricor. Piece
> India's Dr. Reddy's Laboratories launched a pain relief cream, Supamove, that it licensed from Cymbiotics. Report
Biotech News
@FierceBiotech: FDA dishes out long-awaited guidance on social media. Article | Follow @FierceBiotech
@JohnCFierce: In case you missed last week's news, Alexion scoops up promising rare disease drug in $1.08B Enobia buyout. Story | Follow @JohnCFierce
@RyanMFierce: Accelrys paying $35M cash in VelQuest buyout, expanding from R&D software to tech for drug manufacturers. Release | Follow @RyanMFierce
> Aveo cancer drug beats Nexavar in risky PhIII face-off. Article
> Alexion scoops up rare disease drug in $1.08B Enobia buyout. News
Pharma Manufacturing News
> Flu vax tool aids strain identification, timing. Story
> Hospira enters angry-investor phase of remediation. Article
> Ben Venue lengthens remediation timeline. Item
> Infant pain reliever dosing 'fix' shows label limitations. Report
> Rockline quietly recalls contaminated wipes. News
> H&P/Triad, under decree, will recondition seized wipes. More
Biotech Research News
> Fish oil wipes out leukemia in mice. News
> Researchers decode some kidney cancer secrets. Item
> Johns Hopkins tapping genomes to find out why so many African-Americans get asthma. News
Biotech IT News
> FDA dishes out long-awaited guidance on social media. Article
> Poor patient recruitment cited in call for trial disclosures. Story
And Finally... Drug-resistant TB may be caused by patients with faster-than-normal metabolism rather than inconsistent dosing, a new study suggests. Report